[2-(tert-Butoxycarbonylamino)pyrimidin-5-yl]boronic acid is a heterocyclic boronic acid derivative. It features a pyrimidine ring substituted with a Boc-protected amino group at the 2-position and a boronic acid group at the 5-position. This bifunctional structure makes it a valuable building block in organic synthesis, particularly in Suzuki-Miyaura cross-coupling reactions, which are widely used for constructing biaryl and heterobiaryl systems. This compound is primarily utilized as a key intermediate in medicinal chemistry research and pharmaceutical development. The pyrimidine core is a privileged scaffold in drug discovery, commonly found in molecules targeting kinases, enzymes, and various receptors. The presence of the Boc-protected amino group allows for further selective functionalization, making this reagent crucial for the synthesis of complex bioactive molecules, including potential active pharmaceutical ingredients (APIs) and their intermediates. As a boronic acid, it requires careful handling and storage under inert conditions to prevent protodeboronation and maintain reactivity. Its primary value lies in its role as a specialized, application-oriented synthetic building block for constructing drug-like compounds, rather than as a general-purpose reagent.